Perspectives for the future
In the future, physicians will be able to provide more personalized treatments to patients based on their genomic profiles. As this new approach to patient care and personalized medicine continues, a large amount of genomic data on patients will be available. The research can be used to guide best practices across a wide range of indications and create patient success stories [3].
In the future, medicine will become an information science. Information processing is an essential component of health-care, which extends beyond simply converting medical and genomic data to digital formats. Over the next 10 years, we may have an enormous amount of data on each individual. It is IT (Information Technology) hardware or software that can turn that into real hypotheses about each patient [32].
The use of Personalized Medicines will result in more affordable and effective healthcare, access to novel biomedical methods, and a better grasp of one’s own health and genomic information by individuals as well as economic growth in the healthcare sector [33].
Many prescription medicines are ineffective for many people. In 2015, the top 10 grossing pharmaceutical products in the US only benefited 23 to 1 in 4 people. The worst thing about this drug is that sometimes drugs may not work, but may still cause side effects.
In the pipeline, 45% of new medicines can be personalized. Seventy-five percent of cancer drugs could be customized. The expected increase in personalised medicine investment over the next 5 years is 35 percent.

Conclusion

There is still much to learn about personalizing medicine. In the present era of healthcare, it is possible to select medication based on a patient’s genetic makeup, which reduces adverse side effects and ensures better health. In the future, personalized medications could have a positive impact on the healthcare system by providing each person’s full genomic profile details on the day of their birth to put into an individual healthcare record. Clinicians and doctors will be able to adopt more reliable and efficient healthcare approaches using genomic data based on patient exposure to multiple diseases. In the future, only firms that invest in pharmacogenomics and personalized medicine will be able to survive in the pharmaceutical industry. Genetic profiles will be linked to large knowledge bases in order to offer custom-designed diagnosis and treatment to individual patients. In the future, different diagnostic tools will be used to identify and evaluate diseases at various stages. Furthermore, this will also be an opportunity for new players to enter the Pharmaceutical market by bringing innovative ideas to the market. In the future, the pharmaceutical market will shift from a mass market to one that offers specialized products.
Conflict of Interest Statement : The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.